Drugs / Bretzri
last change Jul 2026 re-read 2 minutes ago

Bretzri

Developed for
chronic obstructive pulmonary disease
Investigated by
AstraZeneca · University of Miami

Trials 1 · a red edge is where a trial was stopped

202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT05607719 Apr 2023 → Jul 2026 overdue chronic obstructive pulmonary disease University of Miami Active not recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Bretzri ClinicalTrials.gov intervention name — accepted as the source's own label NCT05607719